Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.77
-0.54 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
38.51
-0.26 (-0.67%)
After-hours: Dec 5, 2025, 7:58 PM EST
Cogent Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -294.37 | -255.86 | -192.41 | -140.24 | -72.27 | -74.81 | |
| Depreciation & Amortization | 4.55 | 4.35 | 3.59 | 5.88 | 1.99 | 0.72 | |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | -7.49 | |
| Asset Writedown & Restructuring Costs | - | - | - | -0.4 | - | 44.81 | |
| Loss (Gain) From Sale of Investments | -3.51 | -7.62 | -5.17 | -1.64 | - | - | |
| Stock-Based Compensation | 40.31 | 39.74 | 30.62 | 18.37 | 11.69 | 6.02 | |
| Other Operating Activities | - | - | -1.7 | -1.36 | -0.34 | 0.22 | |
| Change in Accounts Receivable | - | - | - | - | - | 2 | |
| Change in Accounts Payable | 0.97 | 1.36 | 4.81 | 2.36 | 2.75 | -2.45 | |
| Change in Unearned Revenue | - | - | - | - | - | -1.32 | |
| Change in Other Net Operating Assets | 5.78 | 10.24 | 6.63 | -1.61 | -2.58 | -3.55 | |
| Operating Cash Flow | -245.92 | -207.79 | -153.62 | -118.64 | -58.76 | -35.85 | |
| Capital Expenditures | -0.82 | -0.57 | -2.8 | -6.86 | -1.72 | - | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.32 | |
| Investment in Securities | -14.27 | 38.85 | -95.03 | -117.86 | - | - | |
| Other Investing Activities | - | - | - | - | - | 8.1 | |
| Investing Cash Flow | -15.09 | 38.28 | -97.82 | -124.72 | -1.72 | 8.42 | |
| Issuance of Common Stock | 257.7 | 226.15 | 174.24 | 174.36 | 39.26 | 140.56 | |
| Other Financing Activities | -17.4 | -11.7 | -10.7 | -10.8 | -1.29 | -12.76 | |
| Financing Cash Flow | 289.59 | 214.45 | 163.54 | 163.56 | 37.98 | 232.2 | |
| Net Cash Flow | 28.59 | 44.94 | -87.91 | -79.8 | -22.51 | 204.77 | |
| Free Cash Flow | -246.73 | -208.36 | -156.42 | -125.5 | -60.48 | -35.85 | |
| Free Cash Flow Margin | - | - | - | - | - | -455.47% | |
| Free Cash Flow Per Share | -2.07 | -2.00 | -1.96 | -2.13 | -1.56 | -3.23 | |
| Levered Free Cash Flow | -140.29 | -115.91 | -86.68 | -67.08 | -31.78 | -15.46 | |
| Unlevered Free Cash Flow | -139.55 | -115.91 | -86.68 | -67.08 | -31.78 | -15.46 | |
| Change in Working Capital | 6.75 | 11.6 | 11.44 | 0.75 | 0.18 | -5.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.